HANABOL 250mg|ml Injection 1mlx3 helps in the growth, development, and functioning of the male sexual organs and typical secondary sexual characteristics. This medicine works by supplying synthetic HANABOL 250mg|ml Injection 1mlx3 to replace the HANABOL 250mg|ml Injection 1mlx3 that is normally produced in the body. It is used to treat breast cancer by stopping the release of estrogen.
Side effects
Major & minor side effects for HANABOL 250mg|ml Injection 1mlx3

Enlargement of breasts in males

Weight gain

Acne

Hair loss

Trouble sleeping

Fast or slow or irregular heartbeat rare

Pain at the injection site

Uses of HANABOL 250mg|ml Injection 1mlx3
What is it prescribed for?

Male hypogonadism
This medicine is used to treat hypogonadism, a condition in which the body does not produce enough HANABOL 250mg|ml Injection 1mlx3 due to decreased functioning of male sex organs.

Delayed Puberty (Male)
This medicine is used to treat delayed puberty in males.

Breast cancer
This medicine is used to treat breast cancer by stopping the release of estrogen.

Concerns

Frequently asked questions

Onset of action
The amount of time required for this medicine to show its action is not clinically established.

Duration of Effect
The amount of time for which this medicine remains active in the body is not clinically established.

Safe with Alchohol?
Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Is it habit forming?
No habit-forming tendencies were reported.

Usage in pregnancy?
This medicine is not recommended for use in pregnant women.

Usage while breast-feeding?
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Discuss all the risks and benefits with your doctor before administering this medicine.

When not to use?

Allergy
This medicine is not recommended for use in patients with a known allergy to HANABOL 250mg|ml Injection 1mlx3 or any other inactive ingredients present along with the formulation.

Breast cancer in males
This medicine is not recommended for use in men with breast cancer.

Prostate cancer
This medicine is not recommended for use in patients with a known history of prostate cancer.

Pregnancy
This medicine is not recommended for use in patients with a known pregnancy or suspected pregnancy.

Warnings

Warnings for special population

Pregnancy
This medicine is not recommended for use in pregnant women.

Breast-feeding
This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Discuss all the risks and benefits with your doctor before administering this medicine.

General Warnings

Prostate cancer
This medicine should be used with caution in geriatric patients due to an increased risk of prostate cancer. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Heart diseases
This medicine should be used with extreme caution in patients with a known history of heart diseases due to the increased risk of a heart attack and stroke. Close monitoring of heart function is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Fluid retention
This medicine should be used with caution in patients with fluid retention and edema due to the increased risk of worsening of the patient’s condition. Close monitoring of fluid and electrolytes level is recommended for such patients.

Polycythemia
This medicine should be used with caution in patients with a known history of polycythemia (increased red blood cell count) due to the increased risk of worsening of the patient’s condition. Close monitoring of hemoglobin and hematocrit levels is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

Hypercalcemia
This medicine should be used with extreme caution in patients with a history of hypercalcemia (increased blood calcium levels), hyperparathyroidism (overproduction of parathyroid hormone in the body), or kidney dysfunction due to the increased risk of worsening of the patient’s condition. Close monitoring of calcium levels is recommended for such patients. Appropriate corrective measures, dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

HANABOL 250mg|ml Injection 1mlx3 abuse
This medicine is not recommended for use in higher doses than prescribed. If HANABOL 250mg|ml Injection 1mlx3 abuse is suspected, frequent monitoring of serum HANABOL 250mg|ml Injection 1mlx3 levels should be done to ensure that they are in the therapeutic range.

Dosage

Missed Dose
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of a missed dose is very low.

Overdose
Since this medicine is administered in the hospital or clinical setting by a qualified healthcare professional, the likelihood of an overdose is very low. However, emergency medical treatment will be initiated by the doctor if an overdose is suspected.

Interactions
Interaction with Medicines

Leflunomide severe

Levothyroxine moderate

Anticoagulants severe

Fluconazole moderate

Glimepiride moderate

Disease interactions

severe
This medicine is not recommended for use in male patients with carcinoma of the breast or prostate since it may worsen the patient’s condition. An alternative treatment option should be considered based on clinical conditions.

severe
This medicine should be used with extreme caution in patients with fluid overload and edema due to the increased risk of worsening of the patient’s condition. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

severe
This medicine should be used with caution in patients with a known history of bleeding disorders due to the increased risk of excessive bleeding. Close monitoring of prothrombin time or INR is recommended for such patients. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

moderate
This medicine may cause a sudden drop in blood glucose levels when used along with antidiabetic medicines. Close monitoring of blood glucose levels is necessary for patients with diabetes while using this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition.

moderate
This medicine should be used with extreme caution in patients with liver diseases due to the increased risk of worsening of the patient’s condition. Report any unusual signs and symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition. It is not recommended for use in patients with severe liver diseases.

moderate
This medicine should be used with extreme caution in patients with kidney diseases due to the increased risk of worsening of the patient’s condition. Report any unusual signs and symptoms to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition. It is not recommended for use in patients with severe kidney diseases.

General Instructions

This medicine is usually administered in the clinical/hospital setting under the supervision of a qualified healthcare professional. Follow all the instructions given by your doctor. Inform the doctor if you have a known allergy to this medicine. Report all your current medicines as well as your medical conditions to the doctor before receiving this medicine.

Other details

Usage does not depend on food timings

To be taken as instructed by doctor

Does not cause sleepiness

References

drugbank –
Testosterone [Internet].
Available from: https://go.drugbank.com/drugs/DB00624
[cited 12/31/2020].
2020